According to filings with the U.S. Securities and Exchange Commission, LifeAire Systems is raising $2,000,000.00 in new funding. Sources indicate that as part of senior management Chief Executive Officer, Kathryn Worrilow played a key role in securing the recent investment and it will aid in aggressively expanding the company, as well as broaden and accelerate product development.

About LifeAire Systems
LifeAire Systems is an innovative healthcare technology company whose revolutionary air filtration systems remediate up to 99.999% of biological and chemical contaminants within the air. Developed by a leading embryologist following over a decade of research, LifeAire was originally designed to remove the variable of ambient air during the in vitro fertilization process. LifeAires patented, multi-stage purification media has resulted in significant, documented improvement in clinical outcomes. The system is powerful enough to eradicate anthrax. With its success in protecting the most fragile life formthe human embryo–by removing or neutralizing virtually all airborne threats within an IVF laboratory, LifeAire is expanding its technology into the life sciences and healthcare sectors. LifeAire provides a 9-log reduction in airborne pathogens responsible for Hospital Associated Infections (HAIs), thus improving overall patient safety during surgical procedures and in critical care environments.

To learn more about LifeAire Systems, visit http://lifeaire.com/

Contact:
Kathryn Worrilow, Chief Executive Officer
484-224-3042

SOURCE: http://www.intelligence360.io
Copyright (c) 2023 SI360 Inc. All rights reserved.